Logo main
  • PROMOTE YOUR VENTURE
    • Startup listings
    • IP & Tech listings
  • GET HELP
    • Search questions
    • Post projects
    • Search expert directory
  • RESOURCES
    • Document Center
    • Search for patents
    • Expert articles / posts
  • NEWS & EVENTS
    • Tech & IP News
  • My Account
  • Sign in
  • FOR PROFESSIONALS
  • Icon jp

Patents

68,018 found
SEE ALL IP TYPES
PATENTFIELD SEARCH
UPLOAD IP
Pending

Cancer

Cancer Listeni/ˈkænsər/, also known as a malignant tumor or malignant neoplasm, is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the bo...

Pending

Heart pump

Heart pump

Pending

Nanoparticles for drug deli...

Nanotechnology has provided the possibility of delivering drugs to specific cells using nanoparticles. The overall drug consumption and side-effects may be lowered significantly by depositing th...

Granted

Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a category of cancer treatment that uses chemical substances, especially one or more anti-cancer drugs (chemotherapeutic agents...

Granted

Chemotherapy

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a category of cancer treatment that uses chemical substances, especially one or more anti-cancer drugs (chemotherapeutic agents...

Pending

Anti-thrombogenic compositions

Anti-thrombogenic compositions

Pending

Salmonella infection

Salmonellosis is an infection caused by Salmonella bacteria. Most people infected with Salmonella develop diarrhea, fever, vomiting, and abdominal cramps 12 to 72 hours after infection. In most cas...

Pending

Neointimal stenosis

Neointimal stenosis

Pending

LPA1 receptors

Lysophosphatidic acid receptor 1 also known as LPA1 is a protein that in humans is encoded by the LPAR1 gene.[1][2][3] LPA1 is a G protein-coupled receptor that binds the lipid signaling molecule l...

Pending

Immunotherapy

Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response".[1] Immunotherapies designed to elicit or amplify an immune response are classified as activati...

Pending

KRAS/Cancer

This proto-oncogene is a Kirsten ras oncogene homolog from the mammalian ras gene family. A single amino acid substitution, and in particular a single nucleotide substitution, is responsible for an...

Pending

HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and acquired immunodeficiency syndrome (AIDS).[1][2] AIDS is a condition in humans in whi...

Granted

Tissue analysis

Tissue analysis

Pending

A[beta]-modulated disease

Aβ is the main component of amyloid plaques (extracellular deposits found in the brains of patients with Alzheimer's disease).[19] Similar plaques appear in some variants of Lewy body dementia and ...

Granted

Drug delivery

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.[1] It ...

Pending

Biopolymer

Biopolymers are polymers produced by living organisms; in other words, they are polymeric biomolecules. Since they are polymers, biopolymers contain monomeric units that are covalently bonded to fo...

Pending

Cancer

Cancer Listeni/ˈkænsər/, also known as a malignant tumor or malignant neoplasm, is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the bo...

Pending

Inflammatory diseases

Inflammatory abnormalities are a large group of disorders that underlie a vast variety of human diseases. The immune system is often involved with inflammatory disorders, demonstrated in both aller...

Pending

HIV-1 infection

HIV-1 is the most common and pathogenic strain of the virus. Scientists divide HIV-1 into a major group (Group M) and two or more minor groups. Each group is believed to represent an independent tr...

Pending

Diminishing CTL exhaustion

Diminishing CTL exhaustion

  • First
  • Prev
  • …
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • 261
  • 262
  • …
  • Next
  • Last
Your one-stop shop for innovation and intellectual property Join us today

About us

IP Nexus is an IP commercialisation company that builds successful startup companies by collaborating with inventors, universities and research institutes to identify high-potential inventions at an early stage and provide the commercial direction, fundraising expertise and management talent necessary to build outstanding companies. IP Nexus has particular focus and expertise in Asia.

Disclaimer

IP Nexus, including the Ask an Expert and Services Marketplace, is an interactive online service that makes it faster and easier for businesses to find and hire legal help solely based on their search preferences. We are not a law firm, do not provide any legal services, legal advice or lawyer referral services and do not provide or participate in any legal representation.

Content

  • PRICING
  • FREQUENTLY ASKED QUESTIONS
  • IP PROTECTION
  • IP TYPES
  • IP CLAIMS
  • OUR TEAM
  • STARTUPS
  • CONTACT US
  • BRAND ASSETS
  • TERM OF USE
  • PRIVACY POLICY
  • SEARCH PATENTS ON PATENTFIELD

Newsletter

Subscribe

Languages

Icon jp

Logo gray © 2025 IP Nexus. All Rights Reserved.

Report content

      Contact form